EPFL research groups
Cathrin Brisken
Breast cancer, mouse genetic, mammary gland development, mouse models, patient derived xenografts, estrogen and progesterone, endocrine disruptors
Michele De Palma
Tumor-associated macrophages, tumor angiogenesis and antiangiogenic therapy Immunotherapy, microRNAs, exosomes and extracellular vesicles, mouse models of cancer, immune cell engineering, lentiviral vector technologies
Douglas Hanahan
Cancer, translational oncology, genetically engineered mouse models of human cancer, tumor microenvironment, angiogenesis, invasion, metastasis, pre-clinical trials
Joerg Huelsken
Tumor heterogeneity and stemness in cancer
Freddy Radtke
Notch, stem and progenitor cells, self-renewing tissues, differentiation, cancer, genetic mouse models
Elisa Oricchio
Cancer genetic, mouse models, therapy, stem cells, lymphoma
Wouter Karthaus
Endocrine cancers, endocrine therapy resistance, stem cell biology, organoid technology
Sebastian Waszak
Computational neuro-oncology, biomedical data science, clinical cancer genomics, diffuse midline glioma, diffuse intrinsic pontine glioma, medulloblastoma, genetic tumour syndromes
Affiliated research groups
Giovanni Ciriello
Cancer genomics & evolution, cell plasticity, chromatin 3D architecture, computational biology
Christoph Merten
Microfluidic technology develpment, single cell analysis, antibody discovery, personalized cancer therapy
Andrea Ablasser
DNA sensing, inflammation, antitumor immunity, cGAS-STING pathway
George Coukos
Tumor immunology, T-cell therapies, cancer vaccines, bioinformatics and engineering, clinical trials
Tatiana Petrova
Transcription, differentiation, cancer stem cells, intestinal and vascular development, lymphedema, cancer